295 related articles for article (PubMed ID: 27685608)
1. Omalizumab in patient with aspirin exacerbated respiratory disease and chronic idiopathic urticaria.
Porcaro F; Di Marco A; Cutrera R
Pediatr Pulmonol; 2017 May; 52(5):E26-E28. PubMed ID: 27685608
[TBL] [Abstract][Full Text] [Related]
2. Effect of omalizumab on outcomes in patients with aspirin-exacerbated respiratory disease.
Jean T; Eng V; Sheikh J; Kaplan MS; Goldberg B; Jau Yang S; Samant S
Allergy Asthma Proc; 2019 Sep; 40(5):316-320. PubMed ID: 31514790
[No Abstract] [Full Text] [Related]
3. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
4. Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).
Simon RA; Dazy KM; Waldram JD
Curr Allergy Asthma Rep; 2015 Mar; 15(3):508. PubMed ID: 25663486
[TBL] [Abstract][Full Text] [Related]
5. Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.
Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Tomita Y; Kamide Y; Tsuburai T; Sekiya K; Ishii M; Hasegawa Y; Taniguchi M
J Allergy Clin Immunol; 2023 Jun; 151(6):1667-1672.e2. PubMed ID: 36967017
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases].
Jandus P; Harr T; Soyka MB; Landis BN
Rev Med Suisse; 2019 Oct; 15(665):1748-1751. PubMed ID: 31580018
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Tan JHY; Hsu AAL
Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis.
Stevens W; Buchheit K; Cahill KN
Curr Allergy Asthma Rep; 2015 Dec; 15(12):69. PubMed ID: 26475526
[TBL] [Abstract][Full Text] [Related]
9. Aspirin desensitization achieved after omalizumab treatment in a patient with aspirin-exacerbated urticaria and respiratory disease.
Guillén D; Bobolea I; Calderon O; Fiandor A; Cabañas R ; Heredia R; Quirce S
J Investig Allergol Clin Immunol; 2015; 25(2):133-5. PubMed ID: 25997307
[No Abstract] [Full Text] [Related]
10. A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.
Cameli P; D'Alessandro M; Bergantini L; Silvestri E; Romaldi A; Emmi G; Parronchi P; Bargagli E
Monaldi Arch Chest Dis; 2020 Aug; 90(3):. PubMed ID: 32885934
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial.
Hayashi H; Fukutomi Y; Mitsui C; Kajiwara K; Watai K; Kamide Y; Nakamura Y; Hamada Y; Tomita Y; Sekiya K; Tsuburai T; Izuhara K; Wakahara K; Hashimoto N; Hasegawa Y; Taniguchi M
Am J Respir Crit Care Med; 2020 Jun; 201(12):1488-1498. PubMed ID: 32142372
[No Abstract] [Full Text] [Related]
12. Prevalence of aspirin-exacerbated respiratory disease in patients with asthma in Turkey: a cross-sectional survey.
Bavbek S; Yilmaz I; Celik G; Aydin O; Erkekol FÖ; Orman A; Kurt E; Ediger D; Dursun B; Abadoğlu O; Ozşeker F; Akkaya E; Karakiş GP; Canbakan S; Yüksel S; Misirligil Z
Allergol Immunopathol (Madr); 2012; 40(4):225-30. PubMed ID: 21889254
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
[TBL] [Abstract][Full Text] [Related]
14. Omalizumab in patients with NSAIDs-exacerbated respiratory disease.
Forster-Ruhrmann U; Stergioudi D; Pierchalla G; Fluhr JW; Bergmann KC; Olze H
Rhinology; 2020 Jun; 58(3):226-232. PubMed ID: 32077449
[TBL] [Abstract][Full Text] [Related]
15. Anosmia and an uncommon nonsteroidal anti-inflammatory drug reaction in a 38-year-old man.
Speck AL; Baldwin JL
Allergy Asthma Proc; 2013; 34(3):292-6. PubMed ID: 23676579
[TBL] [Abstract][Full Text] [Related]
16. Mediator release after nasal aspirin provocation supports different phenotypes in subjects with hypersensitivity reactions to NSAIDs.
Campo P; Ayuso P; Salas M; Plaza MC; Cornejo-García JA; Doña I; Torres MJ; Blanca-López N; Canto G; Guéant JL; Sanak M; Blanca M
Allergy; 2013 Aug; 68(8):1001-7. PubMed ID: 23889565
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to dipyrone in aspirin-exacerbated respiratory disease patients is associated with urticaria.
Agondi RC; Dias GMFS; Assis JP; Pacheco R; Kalil J; Giavina-Bianchi P
Respir Med; 2020; 170():106041. PubMed ID: 32843172
[TBL] [Abstract][Full Text] [Related]
18. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Mullol J; Picado C
Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
[TBL] [Abstract][Full Text] [Related]
20. Chronic Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease.
Dunn NM; Katial RK
Immunol Allergy Clin North Am; 2016 Aug; 36(3):503-14. PubMed ID: 27401622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
